thrombotic thrombocytopenia (VITT) is a rare adverse effect of adenovirus‐based severe
acute respiratory syndrome‐coronavirus 2 (SARS‐CoV‐2) vaccines. In March 2021, after
autoimmune pathogenesis of VITT was discovered, treatment recommendations were
developed. These comprised immunomodulation, non‐heparin anticoagulants, and
avoidance of platelet transfusion. The aim of this study was to evaluate adherence to these …